UTHR – united therapeutics corporation (US:NASDAQ)
Stock Stats
News
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $218.00 to $240.00. They now have a "neutral" rating on the stock.
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales [Yahoo! Finance]
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $375.00 to $400.00. They now have an "outperform" rating on the stock.
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Form 4 UNITED THERAPEUTICS Corp For: May 01 Filed by: ROTHBLATT MARTINE A
Form 144 UNITED THERAPEUTICS Corp Filed by: CAUSEY CHRISTOPHER
Form 144 UNITED THERAPEUTICS Corp Filed by: Olian Judy D.
Form 144 UNITED THERAPEUTICS Corp Filed by: SULLIVAN LOUIS W
Form 4 UNITED THERAPEUTICS Corp For: Apr 29 Filed by: ROTHBLATT MARTINE A
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.